Scalp Wounds
Sternal Wounds
Abdominal
Wounds
Flap Donor
Wounds
Fasciotomy
Wounds
Diabetic
Wounds
Achieves delayed primary closure usually
within 5 to 7 days.
Trauma
Wounds
• Alternative to split thickness skin grafts
and associated complications
1
• Off-loads high-tension closures
1
• Maintains a continuous pulling force
with no tightening required
1-3
• Cost effective—Studies show significant
cost savings vs other modalities for closing
traumatic wounds and fasciotomies
2,3
Rx Only. For safe and proper use of this device, refer to the Instructions for Use.
Dermaclose and GEM design are trademarks of Baxter International Inc., or its subsidiaries.
INDICATIONS FOR USE: The DERMACLOSE Continuous External Tissue Expander is indicated for use in assisting with the closure of
moderate to large surgical or traumatic acute full thickness wounds of the skin by approximating and reducing the size of the wound.
CONTRAINDICATIONS: The DERMACLOSE Continuous External Tissue Expander should not be used on ischemic, infected, or acute
burned tissue. It should not be used on fragile tissue at the edges of a wound.
References: 1. DermaClose IFU. Synovis Micro Companies Alliance, Inc. 2. Santiago GF, Bograd G, Basile PL, et al. Soft tissue injury
management with a continuous external tissue expander. Ann Plast Surg. 2012;69(4):418-421. 3. Tauber D, Lee J, Patel A, et al. Efficacy
And Cost Effectiveness In Fasciotomy Closure Using Continuous External Tissue Expansion. Poster
Presented at the Northeast Society of Plastic Surgeons Meeting, September 21st, 2013, Washington,
DC; Albany Medical Center, Albany, NY. The Mayo Clinic, Rochester, MN.
Global Excellence in Microsurgery
Synovis Micro Companies Alliance, Inc. (a subsidiary of Baxter International Inc.) • 439 Industrial Lane, Birmingham, AL 35211
Call: 800-510-3318 or 205-941-0111 • www.synovismicro.com • Email: smca_Information@Baxter.com